Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07412002 · ClinicalTrials.gov registry record
Quality of End-of-Life Care for Children With Cancer
A clinical trial, sponsored by Children's Oncology Group.
- Recruiting
- Registry status
- 2,425
- Enrollment target
NCT07412002: Recruiting study, sponsored by Children's Oncology Group.
NCT07412002 is a clinical trial that is actively recruiting participants, run by Children's Oncology Group. The registered enrollment target is 2,425 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07412002 is actively recruiting participants, sponsored by Children's Oncology Group.
- RECRUITING
- Registry status
- 2,425 participants
- Enrollment target
Study Summary
This study examines the role of access to care, patient/family interactions with the healthcare system, and stress in explaining variations in quality of end of life care. The data collected from this study may help researchers develop a model for identifying patients at risk of low quality end of life care as well as recommendations for potential future interventions.
Primary Outcome
Is a composite measure evaluated as the percent of applicable measures with high-quality care for each patient. For each child, will calculate the percent of measures applicable to that patient for which they met the criteria for high-quality care. Of note, not all measures will apply to every patient (e.g., assessment of sibling support will only apply to those with siblings). EOL quality will be treated as a continuous variable.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,425 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2031-01-31 |
What NCT07412002 shows while recruiting
NCT07412002 is an observational study that tracks outcomes without assigning an intervention. Its 2,425 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT07412002 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07412002 about?
NCT07412002 is a clinical study titled "Quality of End-of-Life Care for Children With Cancer". This study examines the role of access to care, patient/family interactions with the healthcare system, and stress in explaining variations in quality of end of life care. The data collected from this study may help researchers develop a model for identifying patients at risk of low quality end of l...
What is the current status of trial NCT07412002?
This trial is currently recruiting. The enrollment target is 2,425 participants. The study started on 2026-06-15. Estimated completion is 2031-01-31.
What interventions are being tested in trial NCT07412002?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT07412002?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05345951 · 2,425 participants · NA
Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis Use
- NCT05873387 · 2,420 participants
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
- NCT06676904 · 2,433 participants · NA
Neonatal Platelet Transfusion Threshold Trial
- NCT06128304 · 2,436 participants · NA
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI